Evidence map›Paper›PMID 37465939›Full record

ArticleTransfusion2023

Asian-type DEL (RHD*DEL1) with an allo-anti-D: A paradoxical observation in a healthy multiparous woman.

Hitoshi Ohto, Shoichi Ito, Kshitij Srivastava, Yoshiko Ogiyama, Makoto Uchikawa, Kenneth Eric Nollet, Willy Albert Flegel

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Transfusion, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. IntegratingMedicina (Kaunas, Lithuania) · 2025
    Article
  5. Article
  6. A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite NormalTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hitoshi OhtoDepartment of Mesenchymal Stem Cell Research, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0003-0340-883X
Shoichi ItoTohoku Block Blood Center, Japanese Red Cross Society, Sendai, Japan.
Kshitij SrivastavaDepartment of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-3658-0815
Yoshiko OgiyamaTohoku Block Blood Center, Japanese Red Cross Society, Sendai, Japan.
Makoto UchikawaKanto-Koshinetsu Block Blood Center, Japanese Red Cross Society, Tokyo, Japan.
Kenneth Eric NolletDepartment of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Willy Albert FlegelDepartment of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-1631-7198
Japanese Red Cross Society, Japan · JPFukushima Medical University · JPNational Institutes of Health Clinical Center · US

Funding

Laboratory Services Section, Department of Transfusion Medicine Core ReportZICCL002128 · CLC · CLINICAL CENTER · PI FLEGEL, WILLY · 2020 to 2025
$0k
Intramural NIH HHS ZIC CL002128
6 · The paper itself

Abstract

backgroundThe DEL phenotype is the D variant expressing the least amounts of D antigen per red cell. Asian-type DEL (RHD:c:1227G > A) is the most prevalent DEL in East Asia without any anti-D alloimmunization reported before. We investigated the first observation of an anti-D in any DEL phenotype, reported in the Japanese language at a 1987 conference, only 3 years after the discovery of DEL.

methodsWe contacted the proband 35 years after the initial report. Standard hemagglutination, adsorption/elution, and flow cytometry tests were performed, as was nucleotide sequencing for the RHD, RHCE, and HLA class I and class II genes.

resultsThe healthy multiparous Japanese woman, a regular blood donor, still had the anti-D of titer 8 representing an alloantibody by standard serologic methods. Unexpectedly, she carried an Asian-type DEL without any additional RHD gene variation. All 12 HLA alleles identified were known in the Japanese population. Interestingly, one of her HLA-DRB1 and a variant of her HLA-DQB1 alleles had previously been associated with anti-D immunization.

conclusionWe described an allo-anti-D, maintained for more than three decades, in an Asian-type DEL. The combination of two implicated HLA alleles were rare and could have contributed to the anti-D immunization. Continued monitoring of anti-D immunization events in patients with DEL is warranted, and we discuss possible mechanisms for further study. As only this single observation has been recognized in the last 35 years, the current recommendation is affirmed: Individuals with Asian-type DEL should be treated as Rh D-positive for transfusion and Rh immune prophylaxis purposes.

Indexed as

Rh-Hr Blood-Group SystemRho(D) Immune GlobulinAllelesAsian PeopleBlood TransfusionFemaleGenotypeHumansPhenotypeRh-Hr Blood-Group SystemRHO(D) antibodyRho(D) Immune Globulinalloimmunizationanti-DDELRhRhesus

Identifiers

PMID37465939
PMCPMC10528739
OpenAlexW4384663619

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.